Target mediated drug disposition – a population PKPD analysis of literature data
Drs. Gabrielsson and Wendt will continue to co-present a new case study about analyzing acute…
CertaraMay 30, 2024
Certara to Participate in the Jefferies Global Healthcare Conference
Radnor, PA — May 29, 2024 -- Certara, Inc. (Nasdaq: CERT), a global leader in…
CertaraMay 29, 2024
Secondary Intelligence™ Demo
Discover how Secondary Intelligence™ can support your compound assessments by predicting off-target activities and potential…
CertaraMay 24, 2024
Compound design and synthesis tracking with CROs in the loop
In this webinar Andras Stracz presents the benefits of using a shared system with CROs,…
CertaraMay 23, 2024
How to Improve the Management of Your DMTA Cycle
This webinar helps you find ways to create a seamless workflow for researching small molecules…
CertaraMay 23, 2024
Successful Hypothesis and Synthesis Tracking with Design Hub
You can watch the webinar by clicking the video icon on the right. To learn…
Danielle PillsburyMay 23, 2024
Quantitative systems pharmacology-based exploration of relevant anti-amyloid therapy challenges in clinical practice
Addressing practical challenges in clinical practice after the recent approvals of amyloid antibodies in Alzheimer's…
CertaraMay 22, 2024
CERTAINTY Europe
GREATER CERTAINTY IN DRUG DEVELOPMENT Certainty by Certara offers exclusive access to Certara experts, industry leaders, and…
CertaraMay 22, 2024
